FDA Inspection 1004656 — MedPark Pharmacy, LLC
The FDA completed an inspection of MedPark Pharmacy, LLC on March 10, 2017 in Annapolis, MD. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Annapolis, MD (United States)